Last reviewed · How we verify

NCT03137498

Lidocaine vs Ketorolac for Management of Renal Colic in the Emergency Department

Status unknown Phase 4 Last updated 11 July 2018
What this trial tests

Phase 4 trial testing Lidocaine in Renal Colic in 60 participants. Status unknown.

Timeline
6 March 2017
Primary endpoint
6 March 2019
6 March 2019

Quick facts

Lead sponsorThe Brooklyn Hospital Center
PhasePhase 4
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingquadruple
Primary purposetreatment
Enrollment60
Start date6 March 2017
Primary completion6 March 2019
Estimated completion6 March 2019
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

The Brooklyn Hospital Center

Who can join

18 and older, any sex, with Renal Colic. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The hypothesis of the study is that lidocaine will be as effective as ketorolac in decreasing patient's perception of pain as measured by the 10 point Visual Analogue Scale (VAS). The aim of the study is to compare the safety \& efficacy of lidocaine versus ketorolac for acute pain secondary to renal colic in the Emergency Department (ED).

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Lidocaine

Trials testing the same drug.

Other recruiting trials for Renal Colic

Currently open trials in the same condition.

Other The Brooklyn Hospital Center trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03137498.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing